170 related articles for article (PubMed ID: 19204870)
21. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
Sun YB; Qu X; Zhang X; Caruana G; Bertram JF; Li J
PLoS One; 2013; 8(1):e55027. PubMed ID: 23359116
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with telmisartan and oxacalcitriol suppresses the progression of murine adriamycin nephropathy.
Jeong KH; Asanuma K; Lydia A; Takagi M; Asao R; Kodama F; Asanuma E; Tomino Y
Nephron; 2015; 129(2):143-54. PubMed ID: 25661164
[TBL] [Abstract][Full Text] [Related]
23. Development and Characterization of a Novel FVB-
Watanabe M; Ishii Y; Hashimoto K; Takimoto HR; Sasaki N
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674390
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.
Wang C; Li Q; Zhen J; Xu Y; Sun S
Int J Clin Exp Pathol; 2015; 8(12):15696-707. PubMed ID: 26884839
[TBL] [Abstract][Full Text] [Related]
25. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
El-Shitany NA; El-Haggar S; El-desoky K
Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
[TBL] [Abstract][Full Text] [Related]
26. Curcumin prevents adriamycin nephrotoxicity in rats.
Venkatesan N; Punithavathi D; Arumugam V
Br J Pharmacol; 2000 Jan; 129(2):231-4. PubMed ID: 10694226
[TBL] [Abstract][Full Text] [Related]
27. Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity.
DiSilvestro RA; Liu J; Klaassen CD
Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):163-70. PubMed ID: 8884987
[TBL] [Abstract][Full Text] [Related]
28. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
Sakurai N; Kuroiwa T; Ikeuchi H; Hiramatsu N; Takeuchi S; Tomioka M; Shigehara T; Maeshima A; Kaneko Y; Hiromura K; Kopp JB; Nojima Y
Nephrol Dial Transplant; 2009 Aug; 24(8):2378-83. PubMed ID: 19188342
[TBL] [Abstract][Full Text] [Related]
29. Nephroprotective effect of heparanase in experimental nephrotic syndrome.
Assady S; Alter J; Axelman E; Zohar Y; Sabo E; Litvak M; Kaplan M; Ilan N; Vlodavsky I; Abassi Z
PLoS One; 2015; 10(3):e0119610. PubMed ID: 25786136
[TBL] [Abstract][Full Text] [Related]
30. In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE).
Aluise CD; St Clair D; Vore M; Butterfield DA
Cancer Lett; 2009 Sep; 282(1):25-9. PubMed ID: 19342159
[TBL] [Abstract][Full Text] [Related]
31. Adrenomedullin protects against oxidative stress-induced podocyte injury as an endogenous antioxidant.
Oba S; Hino M; Fujita T
Nephrol Dial Transplant; 2008 Feb; 23(2):510-7. PubMed ID: 17981883
[TBL] [Abstract][Full Text] [Related]
32. Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan.
Mihailovic-Stanojevic N; Jovovic D; Miloradovic Z; Grujic-Milanovic J; Jerkic M; Markovic-Lipkovski J
Nephrol Dial Transplant; 2009 Apr; 24(4):1142-50. PubMed ID: 18987260
[TBL] [Abstract][Full Text] [Related]
33. Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β-catenin activity.
Huang X; Xue H; Ma J; Zhang Y; Zhang J; Liu Y; Qin X; Sun C
J Cell Mol Med; 2019 Jun; 23(6):4443-4453. PubMed ID: 30993911
[TBL] [Abstract][Full Text] [Related]
34. Effects of previous physical training on adriamycin nephropathy and its relationship with endothelial lesions and angiogenesis in the renal cortex.
Faleiros CM; Francescato HD; Papoti M; Chaves L; Silva CG; Costa RS; Coimbra TM
Life Sci; 2017 Jan; 169():43-51. PubMed ID: 27884511
[TBL] [Abstract][Full Text] [Related]
35. The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.
Li C; Ge Y; Peng A; Gong R
Oncotarget; 2015 Nov; 6(37):39493-506. PubMed ID: 26567873
[TBL] [Abstract][Full Text] [Related]
36. Podocyte loss in aging OVE26 diabetic mice.
Teiken JM; Audettey JL; Laturnus DI; Zheng S; Epstein PN; Carlson EC
Anat Rec (Hoboken); 2008 Jan; 291(1):114-21. PubMed ID: 18085629
[TBL] [Abstract][Full Text] [Related]
37. Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.
Ni Y; Wang X; Yin X; Li Y; Liu X; Wang H; Liu X; Zhang J; Gao H; Shi B; Zhao S
J Cell Mol Med; 2018 Nov; 22(11):5450-5467. PubMed ID: 30187999
[TBL] [Abstract][Full Text] [Related]
38. Combination of cilostazol and probucol protected podocytes from lipopolysaccharide-induced injury by both anti-inflammatory and anti-oxidative mechanisms.
He P; Kawamura H; Takemoto M; Maezawa Y; Ishikawa T; Ishibashi R; Sakamoto K; Shoji M; Hattori A; Yamaga M; Ide S; Ide K; Hayashi A; Tokuyama H; Kobayashi K; Yokote K
J Nephrol; 2017 Aug; 30(4):531-541. PubMed ID: 28005239
[TBL] [Abstract][Full Text] [Related]
39. The Use of High-Throughput Transcriptomics to Identify Pathways with Therapeutic Significance in Podocytes.
Solanki AK; Srivastava P; Rahman B; Lipschutz JH; Nihalani D; Arif E
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906131
[TBL] [Abstract][Full Text] [Related]
40. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
